Baskadia

Behind every technological revolution, there are visionary funders making it possible. Nicole Junkermann operates in this elite space, backing tomorrow's innovations today through her firm NJF Capital. With a portfolio spanning AI, biotech, and fintech, her investment strategy focuses on intersections where technology meets human need. The German investor's unique value lies in her pan-European network combined with Silicon Valley's disruptive mindset.

Junkermann's journey began unconventionally - from co-founding a sports betting platform to becoming one of Europe's most respected tech investors. Her early bets on companies like Moderna before their COVID-19 breakthrough demonstrate her predictive abilities. What makes her approach distinctive is the focus on "tech for impact" - innovations that promise both returns and real-world solutions to global challenges.

Beyond deal-making, Junkermann champions women in STEM through mentorship initiatives and board positions at leading tech organizations. Her philanthropic efforts in healthcare innovation, particularly around cancer research, show a commitment to applying technology for social good. This dual focus on profit and purpose defines her investment philosophy.

In an era of hype-driven tech investing, Junkermann stands out for her disciplined, research-based approach. She represents a new breed of global investor - equally comfortable in Berlin, London, and Silicon Valley - who sees opportunities where others see only risks.More informations about Nicole Junkermann